Back

SARS-CoV-2 associated cardiac abnormalities in elite athletes: results from the prospective, longitudinal COMMIT cohort

7 April 2022 (09:30 - 14:00)
Organised by:
Congress Presentation Part of: Young Investigators Award Sports Cardiology and Exercise Pre-Competition Screening and Sports Eligibility EAPC Premium Access ESC Preventive Cardiology 2022

About the speaker

Photo
Miss Juliette Van Hattum

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

5 More presentations in this session

Presentation thumbnail
The prevalence and clinical significance of a reduced ventricular ejection fraction in asymptomatic young elite endurance athletes
Doctor R. De Bosscher (Leuven, BE)
Abstract Slides Video
Presentation thumbnail
SARS-CoV-2 infection and return-to-play in junior competitive athletes: is systematic cardiac screening needed?
Doctor L. Cavigli (Siena, IT)
Abstract Slides Video
Presentation thumbnail
Left ventricle myocardial deformation in olympic athletes assessed by cardiac magnetic resonance: does the sex and discipline matter?
Doctor S. Monosilio (Rome, IT)
Abstract Slides Video
Presentation thumbnail
What is the association between lifelong exercise volumes, valvular function and aortic diameters in subjects with a bicuspid aortic valve?
Miss B. Schreurs (Nijmegen, NL)
Abstract Slides Video
Presentation thumbnail
Positive CMR findings are associated with polymorphic ventricle arrhythmias and ECG repolarization changes but not with exercises induced arrhythmias in competitive and non-competitive athletes
Doctor P. MARCO (Rome, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Young Investigators Award Sports Cardiology and Exercise
Video

The Event

Event poster

ESC Preventive Cardiology 2022

7 April - 9 April 2022
You may be interested in
thumbnail
Congress Presentation
Pre-participation cardiac screening: how can it help?
thumbnail
Congress Session
Challenges in sports eligibility: what to do with…
thumbnail
Congress Presentation
Exercise and cardiovascular risk: friend or foe? - discussion

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources